News summary

Cumulus Neuroscience presents positive trial data for remote brain monitoring platform

Source: Longevity Technology • Published: 18 Sept 2026, 07:31

Summarized by Masters of Longevity from Longevity Technology.

Remote brain-monitoring technology is the focus, previewing an article that outlines trial posters on adherence, usability and cognitive screening methods.

Cumulus Neuroscience presents positive trial data for remote brain monitoring platform
Key Takeaways
  • Interim data reported high adherence and usability for remote multimodal brain monitoring in borderline personality disorder and therapy-resistant depression.
  • A two-minute digital cognitive task performed comparably to clinical benchmarks for Alzheimer’s trial pre-enrichment.
  • Cumulus’s NeuLogiq platform was developed with ten biopharma partners to enable frequent clinic and at-home digital measurements.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.